These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26482534)

  • 1. Engineered microparticles based on drug-polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters.
    Gavini E; Bonferoni MC; Rassu G; Sandri G; Rossi S; Salis A; Porcu EP; Giunchedi P
    Drug Dev Ind Pharm; 2016; 42(4):554-62. PubMed ID: 26482534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2009 May; 35(5):583-93. PubMed ID: 19031311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments.
    Razuc M; Piña J; Ramírez-Rigo MV
    AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release antibiotics for dry powder lung delivery.
    Adi H; Young PM; Chan HK; Salama R; Traini D
    Drug Dev Ind Pharm; 2010 Jan; 36(1):119-26. PubMed ID: 19656005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique.
    Pham HH; Luo P; Génin F; Dash AK
    AAPS PharmSciTech; 2002; 3(1):E1. PubMed ID: 12916954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of gel-forming ocular films based on xyloglucan.
    Mahajan HS; Deshmukh SR
    Carbohydr Polym; 2015 May; 122():243-7. PubMed ID: 25817665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride.
    Mundada AS; Shrikhande BK
    Drug Dev Ind Pharm; 2006 Apr; 32(4):443-8. PubMed ID: 16638682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study.
    Pagar KP; Vavia PR
    Ther Deliv; 2013 May; 4(5):553-65. PubMed ID: 23647274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
    Cipolla D; Wu H; Gonda I; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery.
    Baskakova A; Awwad S; Jiménez JQ; Gill H; Novikov O; Khaw PT; Brocchini S; Zhilyakova E; Williams GR
    Int J Pharm; 2016 Apr; 502(1-2):208-18. PubMed ID: 26899973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
    Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
    J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Curr Drug Deliv; 2012 Mar; 9(2):205-18. PubMed ID: 22023210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of floating drug delivery system of azithromycin.
    Wasnik S; Parmar P; Singh D; Ram A
    Acta Pol Pharm; 2012; 69(3):515-22. PubMed ID: 22594266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.